Written question asked by Marsha De Cordova (Labour) on Monday, 11 December 2017, in the House of Commons. It was due for an answer on Thursday, 14 December 2017 (named day). It was answered by Robin Walker (Conservative) on Thursday, 14 December 2017 on behalf of the Department for Exiting the European Union.
European Banking Authority and European Medicines Agency
- Question
-
What assessment the Government has made of the effect on the UK economy of the (a) European Medicines Agency and (b) European Banking Authority relocating from London to other EU countries.
- Answer
-
The decision to relocate the Agencies was one for the EU27.
We have consulted with industry and discussed issues specifically relating to the EBA and EMA as well as other issues and opportunities relating to the banking and life sciences sectors.
As part of the negotiations, we will discuss how best to continue cooperation in the fields of medicines and banking regulation.
And we are determined to ensure the life sciences sector continues to thrive and the UK’s leading position in financial services is maintained as we leave the EU.
Secondary information
- Type
- Written question
- Reference
- 902952
- Session
- 2017-19
- Subjects
- Location European Banking Authority European Medicines Agency
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2018-11-20 03:28:20 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/902952
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/902952
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/902952